Yuk SH[auth] - Search Results

Year	Number of Results
1992	1
1996	1
1999	1
2001	1
2002	1
2003	1
2004	5
2005	7
2006	3
2008	2
2009	2
2010	7
2011	4
2012	8
2013	4
2014	6
2015	2
2016	5
2017	3
2018	3
2019	2
2021	1
2022	3
2023	1
2024	0

1

Pluronic-based core/shell nanoparticles for drug delivery and diagnosis.

Jung YW, Lee H, Kim JY, Koo EJ, Oh KS, Yuk SH. Jung YW, et al. Among authors: yuk sh. Curr Med Chem. 2013;20(28):3488-99. doi: 10.2174/09298673113209990036. Curr Med Chem. 2013. PMID: 23745558 Review.

2

Pluronics: Intelligent building units for targeted cancer therapy and molecular imaging.

Khaliq NU, Park DY, Yun BM, Yang DH, Jung YW, Seo JH, Hwang CS, Yuk SH. Khaliq NU, et al. Among authors: yuk sh. Int J Pharm. 2019 Feb 10;556:30-44. doi: 10.1016/j.ijpharm.2018.11.064. Epub 2018 Dec 6. Int J Pharm. 2019. PMID: 30529667 Review.

3

Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy.

Ryu JH, Koo H, Sun IC, Yuk SH, Choi K, Kim K, Kwon IC. Ryu JH, et al. Among authors: yuk sh. Adv Drug Deliv Rev. 2012 Oct;64(13):1447-58. doi: 10.1016/j.addr.2012.06.012. Epub 2012 Jul 4. Adv Drug Deliv Rev. 2012. PMID: 22772034 Review.

4

In vivo targeted delivery of nanoparticles for theranosis.

Koo H, Huh MS, Sun IC, Yuk SH, Choi K, Kim K, Kwon IC. Koo H, et al. Among authors: yuk sh. Acc Chem Res. 2011 Oct 18;44(10):1018-28. doi: 10.1021/ar2000138. Epub 2011 Aug 18. Acc Chem Res. 2011. PMID: 21851104 Review.

5

Enhanced delivery of the phototherapeutic nanoparticles via hepatocyte overload.

Kim JY, Kil YC, Yang DH, Park DY, Jang HJ, Park SK, Jung YW, Yoon HY, Kim K, Song D, Yuk SH. Kim JY, et al. Among authors: yuk sh. Colloids Surf B Biointerfaces. 2023 Jan;221:112959. doi: 10.1016/j.colsurfb.2022.112959. Epub 2022 Oct 21. Colloids Surf B Biointerfaces. 2023. PMID: 36343478

6

Phase-transition polymers for drug delivery.

Yuk SH, Bae YH. Yuk SH, et al. Crit Rev Ther Drug Carrier Syst. 1999;16(4):385-423. doi: 10.1615/critrevtherdrugcarriersyst.v16.i4.20. Crit Rev Ther Drug Carrier Syst. 1999. PMID: 10532200 Review.

7

Doxorubicin/heparin composite nanoparticles for caspase-activated prodrug chemotherapy.

Khaliq NU, Sandra FC, Park DY, Lee JY, Oh KS, Kim D, Byun Y, Kim IS, Kwon IC, Kim SY, Yuk SH. Khaliq NU, et al. Among authors: yuk sh. Biomaterials. 2016 Sep;101:131-42. doi: 10.1016/j.biomaterials.2016.05.056. Epub 2016 Jun 2. Biomaterials. 2016. PMID: 27286189

8

Induced phenotype targeted therapy: radiation-induced apoptosis-targeted chemotherapy.

Lee BS, Cho YW, Kim GC, Lee DH, Kim CJ, Kil HS, Chi DY, Byun Y, Yuk SH, Kim K, Kim IS, Kwon IC, Kim SY. Lee BS, et al. Among authors: yuk sh. J Natl Cancer Inst. 2014 Dec 12;107(2):dju403. doi: 10.1093/jnci/dju403. Print 2015 Feb. J Natl Cancer Inst. 2014. PMID: 25505252

9

Clinical Anti-aging Efficacy of Propolis Polymeric Nanoparticles Prepared by a Temperature-induced Phase Transition Method.

An JY, Kim C, Park NR, Jung HS, Koo TS, Yuk SH, Lee EH, Cho SH. An JY, et al. Among authors: yuk sh. J Cosmet Dermatol. 2022 Sep;21(9):4060-4071. doi: 10.1111/jocd.14740. Epub 2022 Jan 9. J Cosmet Dermatol. 2022. PMID: 35001491

10

Influence of Panax ginseng formulation on skin microbiota: A randomized, split face comparative clinical study.

Hou JH, Shin H, Shin H, Kil Y, Yang DH, Park MK, Lee W, Seong JY, Lee SH, Cho HS, Yuk SH, Lee KY. Hou JH, et al. Among authors: yuk sh. J Ginseng Res. 2022 Mar;46(2):296-303. doi: 10.1016/j.jgr.2021.12.002. Epub 2021 Dec 14. J Ginseng Res. 2022. PMID: 35509819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

65 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year